EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitFallberichtOpen Access · CC BY-NC 4.0

MYB/MYBL1::QKI fusion-positive diffuse glioma

Ye Yoon Suh iD, Kwanghoon Lee iD, Yu-Mi Shim iD, Ji Hoon Phi iD, Chul-Kee Park iD, Seung-Ki Kim iD, Seung Hong Choi iD, Hongseok Yun iD, Sung-Hye Park iD

Journal of Neuropathology & Experimental Neurology · 2023

DOI: 10.1093/jnen/nlac123 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Neuropathology & Experimental Neurology, 2023. Verfasst von Ye Yoon Suh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Glioma, Ependymoma, Brain Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korea Health Technology R&D Project, Korea Health Industry Development Institute, Ministry of Health & Welfare, Republic of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The MYB/MYBL1::QKI fusion induces the protooncogene, MYB, and deletes the tumor suppressor gene, QKI. MYB/MYBL1::QKI rearrangement was previously reported only in angiocentric glioma (AG) and diffuse low-grade glioma. This report compares 2 tumors containing the MYB/MYBL1::QKI fusion: a diffuse pediatric-type high-grade glioma (DPedHGG) in an 11-year-old boy and an AG in a 46-year-old woman. We used immunohistochemistry, next-generation sequencing, and methylation profiling to characterize each tumor and compare our findings to the literature on AG and tumors with the MYB/MYBL1::QKI rearrangement. Both tumors were astrocytic with angiocentric patterns. The MYB::QKI fusion-positive DPedHGG, which recurred once, was accompanied by TP53 mutation and amplification of CDK6 and KRAS, suggesting malignant transformation secondary to additional genetic aberrations. The second case was the adult AG with MYBL1::QKI fusion, which mimicked ependymoma based on histopathology and its dot- and ring-like epithelial membrane antigen positivity. Combined with a literature review, our results suggest that MYB/MYBL1 alterations are not limited to low-grade gliomas, including AG. AG is most common in the cerebra of children and adolescents but exceptional cases occur in adults and the acquisition of additional genetic mutations may contribute to high-grade glioma. These cases further demonstrate that molecular characteristics, morphologic features, and clinical context are essential for diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaEpendymomaBrain NeoplasmsMaleAdultFemaleAdolescentHumansChildMiddle AgedNeoplasm Recurrence, LocalMutationProto-Oncogene ProteinsTrans-ActivatorsRNA-Binding Proteins

Stichwörter der Autor:innen

MYB/MYBL1-alterationAngiocentric gliomaMethylation profileNext-generation sequencingPediatric-type high-grade glioma

Substanzen

MYBL1 protein, humanProto-Oncogene ProteinsTrans-ActivatorsQKI protein, humanRNA-Binding Proteins

Autor:innen und Institutionen

  • Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Department of Neurosurgery, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Department of Radiology, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Department of Genomic Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • N euroscience Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.

ORCID-Profile: Ye Yoon Suh, Kwanghoon Lee, Yu-Mi Shim, Ji Hoon Phi, Chul-Kee Park, Seung-Ki Kim, Seung Hong Choi, Hongseok Yun, Sung-Hye Park

Förderung

  • Korea Health Technology R&D Project
  • Korea Health Industry Development Institute
  • Ministry of Health & Welfare, Republic of Korea
  • Institute for Information & Communications Technology Promotion
  • Korean government

Zitieren

APA

Suh, Y. Y., Lee, K., Shim, Y. M., Phi, J. H., Park, C. K., Kim, S. K., Choi, S. H., Yun, H., & Park, S. H. (2023). MYB/MYBL1::QKI fusion-positive diffuse glioma. Journal of Neuropathology & Experimental Neurology. https://doi.org/10.1093/jnen/nlac123

Vancouver

Suh YY, Lee K, Shim YM, Phi JH, Park CK, Kim SK, et al. MYB/MYBL1::QKI fusion-positive diffuse glioma. Journal of Neuropathology & Experimental Neurology. 2023. doi:10.1093/jnen/nlac123

BibTeX
@article{Suh2023,
  author = {Suh, Ye Yoon and Lee, Kwanghoon and Shim, Yu-Mi and Phi, Ji Hoon and Park, Chul-Kee and Kim, Seung-Ki and Choi, Seung Hong and Yun, Hongseok and Park, Sung-Hye},
  title = {MYB/MYBL1::QKI fusion-positive diffuse glioma},
  journal = {Journal of Neuropathology & Experimental Neurology},
  year = {2023},
  doi = {10.1093/jnen/nlac123}
}
Kostenlos starten →